• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Cigna Ventures | Health Care Venture Capital

Cigna Ventures | Health Care Venture Capital

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

News

Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients

October 31, 2022

Valera Health, the leading virtual mental health provider serving high acuity patients, announced today the closing of a $44.5M growth equity raise led by Heritage Group, a healthcare-focused private equity firm, with participation from Cigna Ventures, Horizon Healthcare Services and existing investors, which include Windham Ventures, AXA Venture Partners, Aquiline Technology Partners, Trinnovate Ventures (BCBS […]

READ MORE

Filed Under: News

Zerigo Health Announces Release of Eczema Solution

September 15, 2022

Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the launch of a new software release which includes integration of the American Academy of Dermatology Guideline protocols for the treatment of eczema with narrowband ultraviolet B (NB-UVB) phototherapy. Evernorth, Cigna Corporation’s […]

READ MORE

Filed Under: News

Alma Raises $130M in Series D Funding led by Thoma Bravo to Advance its Mission to Simplify Access to High Quality, Affordable Mental Health Care

August 25, 2022

Alma, a membership-based network that helps independent mental health care providers accept insurance and build thriving private practices, has announced $130 million in Series D funding led by Thoma Bravo, a leading software investment firm, with participation from Cigna Ventures. Existing investors Insight Partners, Optum Ventures, Tusk Venture Partners, Primary Venture Partners, and Sound Ventures also participated […]

READ MORE

Filed Under: News

InterWell Health, Cricket Health, and Fresenius Health Partners Complete Three-Way Merger, Creating Premier, Value-based Kidney Care Provider

August 25, 2022

InterWell Health today announced it has completed a three-way merger between Fresenius Medical Care’s value-based care division, Fresenius Health Partners; InterWell Health, a leading physician organization driving innovation in the kidney care industry; and Cricket Health, a provider of value-based kidney care with an industry-leading patient engagement and data platform. The new independent company, which […]

READ MORE

Filed Under: News, Partnership Activity

Heart Health Innovator Cleerly Closes Series C Funding Round with $192 Million

July 25, 2022

Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192 million. The oversubscribed funding round was led by funds and accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and Fidelity Management and Research Company. […]

READ MORE

Filed Under: News

Three-Way Merger Combines Focus on Physician and Patient Engagement with Industry-Leading Technology Platform to Create the Nation’s Premier, Value Based Kidney Care Provider

March 22, 2022

Fresenius Medical Care, a leading provider of products and services for individuals with kidney diseases, InterWell Health, a leading physician organization driving innovation in the kidney care industry, and Cricket Health, a provider of value based kidney care with an industry-leading patient engagement and data platform, announced today they have entered into a definitive agreement […]

READ MORE

Filed Under: News

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 8
  • Go to Next Page »

Primary Sidebar

Categories

  • News
  • Partnership Activity

More news

  • Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being March 13, 2024
  • 9amHealth Raises $9.5M Series A Extension Led by The Cigna Group Ventures to Expand to Employers Nationwide February 20, 2024
  • Prognos Health Raises $23 Million May 11, 2023
  • Monogram Health’s In-Home Services Now Available to More Older Adults Living with Chronic Kidney Conditions February 7, 2023
  • NOCD Completes Additional Funding in its Quest to End the OCD Crisis January 31, 2023
  • Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care Model January 13, 2023
  • Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients October 31, 2022

Footer

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

By contacting The Cigna Group Ventures through this website, you agree and acknowledge that information you submit will not be considered or treated as confidential or proprietary unless and until a separate agreement is signed and that The Cigna Group Ventures and its affiliates are under no obligation to review your submission or to enter into any agreement, investment or transaction associated with the submission. In no event will The Cigna Group Ventures or any of its affiliates be limited in, or restricted from, the pursuit of any opportunities, either alone or with third parties.

The information contained herein does not constitute a distribution, an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such distribution or offer is not authorized. In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States (U.S.) or for the benefit of any U.S. person (being residents of the United States or partnerships or corporations organized under the laws of the United States), nor in any other country.

The Cigna Group name, logo and other marks are owned by Cigna Intellectual Property, Inc.
Privacy Policy | Terms of Use | Accessibility | Cookie Settings
© 2024 The Cigna Group Ventures. All rights reserved.

This site is protected by Google's reCAPTCHA. Privacy Policy and Terms of Service apply.